SCHEMBL14927013

SCHEMBL14927013

Cc1cc2cc(-c3cccc(-c4ccccc4)c3)nc(N=C(N)N)c2cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 8/20 0.49
▸ PLG P00747 3/20 0.49
▸ ASIC3 Q9UHC3 1/20 0.41
▸ NPFFR1 Q9GZQ6 1/20 0.41
▸ NPFFR2 Q9Y5X5 1/20 0.41
▸ ATP4A P20648 3/20 0.40
▸ ATP4B P51164 3/20 0.40
▸ F9 P00740 1/20 0.39
▸ DHODH Q02127 2/20 0.37
▸ PLAT P00750 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ RAD52 P43351 2/20 0.36
▸ MPO P05164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927010 0.94 PLAU (0.47) PLAUPLGNPFFR1NPFFR2ATP4A
SCHEMBL12070766 0.84 ACACA (0.49) PLAUPLGATP4AATP4BDHODH
SCHEMBL14927020 0.79 GRIN2D (0.41) PLAUPLGASIC3NPFFR1NPFFR2
SCHEMBL14927105 0.78 RAC1 (0.47) KDM4ERAB9AALDH1A1MAPTMEN1
SCHEMBL12070672 0.78 ACACA (0.47) PLAUPLGDHODHKDM4ERAB9A
SCHEMBL130007 0.76 RAC1 (0.49) KDM4ERAB9AALDH1A1MAPTMEN1
SCHEMBL14927081 0.75 L3MBTL1 (0.46) KDM4ERAB9AALDH1A1MAPTMEN1
SCHEMBL14927107 0.75 MAPT (0.37) KDM4ERAB9AALDH1A1MAPTMEN1
SCHEMBL14927106 0.75 MAPT (0.40) KDM4ERAB9AALDH1A1MAPTMEN1
SCHEMBL14927009 0.73 MEN1 (0.42) KDM4ERAB9AALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 PLAU 4639/4885PLG 4846/4885ASIC3 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback